REFERENCES
1. Djernes JK. Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatr Scand. 2006;113(5):372-87.
2. Drayer RA, Mulsant BH, Lenze EJ, Rollman BL, Dew MA, Kelleher K, et al. Somatic symptoms of depression in elderly patients with medical comorbidities. International Journal of Geriatric Psychiatry. 2005;20(10):973-82.
3. Penninx BW, Leveille S, Ferrucci L, van Eijk JT, Guralnik JM. Exploring the effect of depression on physical disability: longitudinal evidence from the established populations for epidemiologic studies of the elderly. American journal of public health. 1999;89(9):1346-52.
4. Cole MG, Bellavance F, Mansour A. Prognosis of depression in elderly community and primary care populations: a systematic review and meta-analysis. American Journal of Psychiatry. 1999;156(8):1182-9.
5. Blazer DG. Depression in late life: review and commentary. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2003;58(3):M249-M65.
6. Unützer J. Late-life depression. New England Journal of Medicine. 2007;357(22):2269-76.
7. Maurer-Spurej E, Pittendreigh C, Solomons K. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thrombosis and haemostasis. 2004;91(01):119-28.
8. Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Archives of internal medicine. 2004;164(21):2367-70.
9. De Abajo FJ, Montero D, García Rodríguez LA, Madurga M. Antidepressants and risk of upper gastrointestinal bleeding. Basic & clinical pharmacology & toxicology. 2006;98(3):304-10.
10. Van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. Bmj. 2001;323(7314):655.
11. Cheng YL, Hu HY, Lin XH, Luo JC, Peng YL, Hou MC, et al. Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding: A Nationwide Population-Based Cohort Study in Taiwan. Medicine (Baltimore). 2015 Nov;94(46):e2022.
12. Loke YK, Trivedi, A. N., & Singh, S. Meta‐analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non‐steroidal anti‐inflammatory drugs. Alimentary pharmacology & therapeutics. 2008;27(1):31-40.
13. Masclee GM, Valkhoff VE, Coloma PM, de Ridder M, Romio S, Schuemie MJ, et al. Risk of upper gastrointestinal bleeding from different drug combinations. Gastroenterology. 2014;147(4):784-92.
14. Targownik LE, Bolton JM, Metge CJ, Leung S, Sareen J. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol. 2009 Jun;104(6):1475-82.
15. Dalton SO, Johansen C, Mellemkjær L, Sørensen HT, Nørgård B, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Archives of internal medicine. 2003;163(1):59-64.
16. de Abajo FJ, & Garcia-Rodriguez, L. A. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Archives of General Psychiatry. 2008;65(7):795-803.
17. De Jong JC, Van Den Berg PB, Tobi H, De Jong LT, Van Den Berg. Combined use of SSRIs and NSAIDs increases the risk of gastrointestinal adverse effects. British journal of clinical pharmacology. 2003;55(6):591-5.
18. Salive ME. Multimorbidity in older adults. . Epidemiologic reviews. 2013;35(1):78-53.
19. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clinical interventions in aging. 2008;3(2):383.
20. van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22(2):209-24.
21. National Health Research Institute. National Health Insurance Research Database (online). Available at:http://nhird.nhri.org.tw/en/index.htm. Accessed November 26.
22. WHO Collaborationg Centre for Drug Statistics Methodology. ATC / DDD Index 2019 (online). Available at:https://www.whocc.no/atc_ddd_index/. Accessed May 21. [cited; Available from:
23. Lin CC, Hu HY, Luo JC, Peng YL, Hou MC, Lin HC, et al. Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study. Aliment Pharmacol Ther. 2013 Nov;38(9):1119-28.
24. Van Leerdam ME, Vreeburg EM, Rauws EAJ, Geraedts AAM, Tijssen JGP, Reitsma JB, et al. Acute upper GI bleeding: did anything change?: Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. American journal of gastroenterology. 2003;98(7):1494-9.
25. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011 Aug 2;343:d4551.
26. Dall M, Schaffalitzky de Muckadell OB, Lassen AT, Hansen JM, Hallas J. An Association Between Selective Serotonin Reuptake Inhibitor Use and Serious Upper Gastrointestinal Bleeding. Clinical Gastroenterology and Hepatology. 2009;7(12):1314-21.
27. Sultana J, Spina, E., & Trifirò, G. Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety. Expert opinion on drug metabolism & toxicology. 2015;11(6):883-92.
28. Salam OMA. Fluoxetine and sertraline stimulate gastric acid secretion via a vagal pathway in anaesthetised rats. Pharmacological research. 2004;50(3):309-16.
29. Brzozowski T, Konturek PC, Konturek SJ, Drozdowicz D, Kwiecieñ S, Pajdo R, et al. Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia–reperfusion into gastric ulcers. European journal of pharmacology. 2000;398(1):147-58.
30. Ji CX, Fan DS, Li W, Guo L, Liang ZL, Xu RM, et al. Evaluation of the anti-ulcerogenic activity of the antidepressants duloxetine, amitriptyline, fluoxetine and mirtazapine in different models of experimental gastric ulcer in rats. European journal of pharmacology. 2012;691(1-3):46-51.
31. Salem Sokar S, Elsayed Elsayad, M., & Sabri Ali, H. Serotonin and histamine mediate gastroprotective effect of fluoxetine against experimentally-induced ulcers in rats. Journal of immunotoxicology. 2016;13(5):638-51.
32. Wiese BS. Geriatric depression: the use of antidepressants in the elderly. BcMJ. 2011;53(7):341-7.
33. Alexopoulos GS. Depression in the elderly. Lancet. 2005;365(9475):1961-70.
34. Bourin M, Chue, P., & Guillon, Y. Paroxetine: a review. CNS drug reviews. 2001;7(1):25-47.
35. Wang YP, Chen YT, Tsai CF, Li SY, Luo JC, Wang SJ, et al. Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding. Am J Psychiatry. 2014 Jan;171(1):54-61.
36. Abdelmalik N, Ruhe HG, Barwari K, van den Dool EJ, Meijers JC, Middeldorp S, et al. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J Thromb Haemost. 2008 Dec;6(12):2168-74.
37. Yu YWY, Tsai SJ, Chen TJ, Lin CH, Hong CJ. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Molecular Psychiatry. 2002;7(10):1115-9.
38. Jiang HY, Chen HZ, Hu XJ, Yu ZH, Yang W, Deng M, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015 Jan;13(1):42-50 e3.
39. Laine L, & Jensen, D. M. Management of patients with ulcer bleeding. The American journal of gastroenterology. 2012;107(3):345.
Figure legends
Fig 1. Odds ratios for UGIB in association with cumulative defined daily dose of prescription for SSRIs classified by tertile of distributions in control group. The models were adjusted for diabetes mellitus, hypertension, coronary artery disease, liver cirrhosis, chronic obstructive pulmonary disease, renal disease, cancer, antiplatelet use, oral anticoagulant use, and NSAID use. Abbreviations: UGIB, upper gastrointestinal bleeding; SSRIs, selective serotonin reuptake inhibitors; cDDD, cumulative defined daily dose.
Fig 2 . Odds ratios for UGIB in association with number of days between the last SSRIs prescription and the index date for each SSRIs categories with use of other SSRIs as the reference. The models were adjusted for diabetes mellitus, hypertension, coronary artery disease, liver cirrhosis, chronic obstructive pulmonary disease, renal disease, cancer, antiplatelet use, oral anticoagulant use, and NSAID use. Abbreviations: UGIB, upper gastrointestinal bleeding; SSRIs, selective serotonin reuptake inhibitors.